Company news
Jp Morgan Chase & Co. (NYSE:JPM) news
Every Jp Morgan Chase & Co. press release and news update in one place — announcements, filings coverage, and company updates for investors.
Press releases — page 3
Chase to Open More Than 160 Branches in Over 30 States in 2026
February 18, 2026
TJ Maxx and JP Morgan Chase Bank Renew Long-Term Retail Leases With Empire State Realty Trust Which Total 68,120 Square Feet
February 17, 2026
XTI Aerospace Secures $20 Million JPMorgan Chase & Co. Asset-Based Lending Facility
February 17, 2026
JPMorganChase Files Form 10-K for the Fiscal Year Ended December 31, 2025
February 13, 2026
JPMorgan Announces Cash Distributions for the JPMorgan ETFs
February 10, 2026
JPMorgan ETFs (Ireland) ICAV: Dividend Declaration
February 5, 2026
Chase and Disney Launch the Disney® Inspire Visa® Card Featuring Exclusive Benefits for Cardmembers
February 3, 2026
Important Notice of Dividend Announcement to shareholder of Xtrackers II
February 3, 2026
J.P. Morgan Private Bank Releases 2026 Global Family Office Report
February 2, 2026
J.P. Morgan Asset Management Launches JPMorgan International Dynamic ETF (JIDE) on NYSE Arca
January 28, 2026
JPMorganChase to Match U.S. Government’s $1,000 Contribution to Trump Accounts for Employees’ Children
January 28, 2026
Turbett Surgical Announces Recapitalization and Growth Investment by J.P. Morgan Life Sciences Private Capital
January 27, 2026
J.P. Morgan Asset Management Welcomes Pam Hess as Retirement Strategist
January 27, 2026
JPMorganChase Company Update 2026
January 23, 2026
Mindray Unveils Three-Pillar Growth Strategy at 2026 J.P. Morgan Healthcare Conference, Paving the Way for Next Decade of Global Healthcare Innovation
January 22, 2026
Women Presidents Organization and J.P. Morgan Commercial Banking Open Nominations for the 2026 50 Fastest Growing Women-Owned/Led Companies™
January 20, 2026
JPMorganChase Declares Preferred Stock Dividends
January 15, 2026
JPMorganChase to Present at the UBS Financial Services Conference
January 14, 2026
Zai Lab Highlights Strategic Priorities and Global Pipeline Progress at 44th Annual J.P. Morgan Healthcare Conference
January 13, 2026
Marea Therapeutics Unveils Positive Topline Phase 1 Data for MAR002 in Acromegaly; Demonstrates Potential for Best-in-Disease Efficacy and Dosing Profile
January 13, 2026
JPMorganChase Reports Fourth-Quarter and Full-Year 2025 Financial Results
January 13, 2026
BeOne Medicines Highlights Global Oncology Leadership at 44th Annual J.P. Morgan Healthcare Conference
January 13, 2026
vVARDIS Founders Present Drill-Free Early Cavity Treatment and Unveil Global Cavity Awareness Campaign at the 2026 J.P. Morgan Healthcare Conference
January 12, 2026
Turn Therapeutics Announces Corporate and Pipeline Updates and 2026 Outlook Ahead of the 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
Nuvation Bio Reports Preliminary Fourth Quarter and Full Year 2025 Financial Results and Provides 2026 Outlook Ahead of 44th Annual J.P. Morgan Healthcare Conference
January 12, 2026
Argo Biopharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 11, 2026
IDEAYA Biosciences Provides a Business Update and Outlines 2026 Corporate Objectives at the 44th Annual J.P. Morgan Healthcare Conference
January 11, 2026
CorMedix Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
iOnctura CEO to present at the 2026 J.P. Morgan Healthcare Conference
January 9, 2026
Averna Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
Insmed Provides Business Update at 44th Annual J.P. Morgan Healthcare Conference
January 9, 2026
SonoThera Launches $125M Series B at 44th J.P. Morgan Healthcare Conference to Advance Multiple Genetic Medicine Programs Toward First-in-Human Studies
January 8, 2026
Encoded Therapeutics Highlights Progress in Dravet Syndrome Program and Pipeline Ahead of Company Presentation at 44th Annual J.P. Morgan Healthcare Conference
January 8, 2026
32 Biosciences to Launch $40 Million Series A at J.P. Morgan to Advance First-in-Class GI Mucosal-Immune Therapeutics
January 8, 2026
Avenacy Provides Update on Business Progress and Announces 2026 Strategic Priorities Ahead of 44th Annual J.P. Morgan Healthcare Conference
January 8, 2026
Enanta Pharmaceuticals Provides Update on its Research and Development Programs and 2026 Outlook
January 8, 2026
Azafaros to Present at J.P. Morgan’s 44th Annual Healthcare Conference
January 8, 2026
Chase to become new issuer of Apple Card
January 7, 2026
Bruker Corporation to Present at the J.P. Morgan Healthcare Conference
January 7, 2026
Masimo to Present in the J.P. Morgan 2026 Healthcare Conference
January 7, 2026
Stylus Medicine to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026
LEO Pharma to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 7, 2026
JPMorganChase Survey: U.S. Business Leaders Signal Optimism and Growth Plans for 2026 Despite Economic Uncertainty
January 7, 2026
Baxter to Present at J.P. Morgan 2026 Healthcare Conference
January 6, 2026
Nuvation Bio to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
Exelixis to Present at the J.P. Morgan 2026 Healthcare Conference on January 12, 2026
January 6, 2026
Stoke Therapeutics to Present at the 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
Helping Los Angeles Heal: JPMorganChase Marks A Year of Support for Wildfire Recovery
January 6, 2026
Acadia Healthcare to Participate in 44th Annual J.P. Morgan Healthcare Conference
January 6, 2026
Kardigan Announces Participation in the 44th Annual J.P. Morgan Healthcare Conference and Provides Corporate Update for 2026
January 6, 2026